HOME >> BIOLOGY >> NEWS
Ossur hf. acquires the Gibaud Group in France

Ossur hf. (ICEX: OSSR), a trusted and leading global supplier of orthopaedic devices, announced today that it has acquired the Gibaud Group in France in a transaction valued at approximately USD 132 million (Euro 101 million). The Gibaud Group is a local leader in the design, production and distribution of medical devices used in the non-invasive orthopaedics sector, specializing in bracing, soft goods and compression therapy products (phlebology). The transaction closed today and Ossur will take over the operations of the Gibaud Group effective immediately.

This is Ossur's second largest acquisition to date, and is in line with Ossur's strategic growth plans in the non-invasive orthopaedics industry.

Commenting on the transaction, Ossur's President & CEO Jn Sigurdsson stated:

"This acquisition is a milestone acquisition for us and in line with our strategy of consolidating the bracing and the soft goods segment of the non-invasive orthopaedics market on a global level. We are also entering a new and important segment of the non-invasive orthopaedics market in Europe, the phlebology segment, which is synergistic with the other non-invasive orthopaedic businesses in Europe."

Gibaud's main product lines are braces & supports and compression therapy products. The bracing and support market in France is estimated to be valued at approximately USD 130 million. Gibaud Group is the second largest player with a market share in excess of 20%. The phlebology market is a new market segment for Ossur. The local French market is estimated to be valued at more than USD 130 million. The Gibaud Group holds more than 10% of the market and is the third largest player on the market. Gibaud's current product lines, strong market position, and knowledge and experience will increase Ossur's opportunities in Europe, especially in southern Europe.

Key benefits of the acquisition of the Gibaud Group:

  • Access to
    '"/>


Contact: Beverly Millson
beverly@missingsock.com
310-804-3469
Ossur
22-Dec-2006


Page: 1 2 3

Related biology news :

1. Ossurs PROPRIO FOOT takes the Gold 2007 Medical Design Excellence Award
2. Ossurs Proprio Foot walks away with 2007 Medical Design Excellence Award
3. Ossur repeats Popular Science Best of Whats New award
4. Ossur recognized with Frost & Sullivan 2006 Innovative Technology Award
5. Ossurs POWER KNEE widely available in September
6. Ossur takes another giant step in prosthetic technology
7. The World Economic Forum announces new class of technology pioneers for 2006: Ossur selected
8. Ossurs Power Knee wins Popular Science magazines 2005 Best of Whats New Award
9. Ossur one of Europes 500 fastest growing companies
10. Ossur congratulates Hugh Herr on Popular Mechanics 2005 Breakthrough Leadership Award
11. Ossur captures Frost & Sullivan Technology of the Year Award for breakthrough RHEO KNEE

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is helping healthcare ... manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen ... more than 10 years. Early in the COVID-19 crisis, we identified supply chain ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is ... ability to discover a COVID cure or vaccine, the global economic downturn will only ... pressure is not going away and capturing full value from every product launch is ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR ... chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 16, 2020 , ... After ... begins. The completion of a great surgery is only the beginning of a successful ... the research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
Cached News: